Calistoga Rolls Out More Evidence for Blood Cancer Drug, Sizes Up Pivotal Trial

Calistoga Pharmaceuticals has been stirring up buzz at medical meetings for more than a year about how its experimental treatment is shrinking tumors for patients with certain blood cancers that resist other therapies.
Xconomy